Rockwell Medical Technologies, Inc. manufactures hemodialysis concentrate solutions and dialysis kits, and sells, distributes and delivers these and other ancillary hemodialysis products to hemodialysis providers in the United States, Latin America, Asia and Europe. Hemodialysis concentrates are comprised of two primary product types, described as acidified dialysate concentrate, also known as acid concentrate, and bicarbonate. Hemodialysis duplicates kidney function in patients with failing kidneys, also known as End Stage Renal Disease (ESRD). Its dialysis solutions (also known as dialysate) are used to maintain life, removing toxins and replacing nutrients in the dialysis patient’s bloodstream. The Company has licensed and is developing renal drug therapies for both iron-delivery and carnitine/vitamin-delivery, utilizing dialysate as the delivery mechanism. In July 2011, the Company acquired abbreviated new drug application (ANDA) for injectable, active Vitamin-D.